Lifyorli Drug Interactions: 18 Major, 647 Moderate
Lifyorli (Relacorilant) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Lifyorli. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Relacorilant can be increased when combined with Abatacept.
Level 1 evidence
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Relacorilant.
Level 1 evidence
Abiraterone
The serum concentration of Abiraterone can be increased when it is combined with Relacorilant.
Level 1 evidence
Acalabrutinib
The serum concentration of Acalabrutinib can be increased when it is combined with Relacorilant.
Level 1 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Relacorilant.
Level 1 evidence
Acetaminophen
The serum concentration of Acetaminophen can be increased when it is combined with Relacorilant.
Level 1 evidence
Adagrasib
The serum concentration of Adagrasib can be increased when it is combined with Relacorilant.
Level 1 evidence
Adalimumab
The metabolism of Relacorilant can be increased when combined with Adalimumab.
Level 1 evidence
Aficamten
The serum concentration of Aficamten can be increased when it is combined with Relacorilant.
Level 1 evidence
Albendazole
The serum concentration of Albendazole can be increased when it is combined with Relacorilant.
Level 1 evidence
Alclometasone
The serum concentration of Alclometasone can be increased when it is combined with Relacorilant.
Level 1 evidence
Alfentanil
The serum concentration of Alfentanil can be increased when it is combined with Relacorilant.
Level 1 evidence
Enter your NPI to unlock 3 major interactions for Lifyorli
Lifyorli (Relacorilant) has 669 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Lifyorli (Relacorilant) has 18 major, 647 moderate, and 4 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Lifyorli. Always confirm against the full prescribing information.